Chagas cardiomyopathy associated with serological cure after trypanocidal treatment during childhood

4Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Chagas disease is a chronic parasitological disease, which could cause cardiac manifestations in approximately one-third of affected individuals. Benznidazole and nifurtimox are used to treat this parasitological infection caused by Trypanosoma cruzi. Conventionally, the criterion for cure is consistently negative serological tests after treatment. We report a case of a patient who was treated when she was 13 years old and achieved T. cruzi negative seroconversion but developed Chagas disease cardiomyopathy as an adult.

Cite

CITATION STYLE

APA

Fernández, M. L., Hernández, Y., Scollo, K., Esteva, M. I., Riarte, A. R., & Prado, N. G. (2018). Chagas cardiomyopathy associated with serological cure after trypanocidal treatment during childhood. Revista Da Sociedade Brasileira de Medicina Tropical, 51(4), 557–559. https://doi.org/10.1590/0037-8682-0364-2017

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free